检索

标题
作者
Clinical significance of intravital morphological investigation of the liver
Khomeriki S., Yakimchuk G., Golovanova E., Homeriki S., Yakimchuk G., Golovanova E.
Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)
Sologub T., Romantsov M., Shul'dyakov A., Lin'kova Y., Radchenko V., Kovalenko A., Sologub T., Romantsov M., Shuldyakov A., Linkova Y., Radchenko V., Kovalenko A.
The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C
Tkachenko L., Maleev V.
Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
Znoyko O., Dudina K., Kozina A., Kalininа O., Yushchuk N.
Chronic hepatitis C in Russia: current challenges and prospects
Chulanov V., Pimenov N., Mamonova N., Sagalova O., Shestakova I., Pokrovsky V.
Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice
Abdurakhmanov D., Otrashevskaia A.
Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
Antonova T., Romanova M., Lymar' I.
Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
Nikitin I., Gogova L., Baĭkova I., Kisliakov V., Volynkina V.
The course and treatment of chronic hepatitis B in HIV-infected patients
Maksimov S., Tsarenko S., Kravchenko A., Yushchuk N., Maksimov S., Tsarenko S., Kravchenko A., Yushchuk N.
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review
Gridneva G., Belov B., Aronova E.
Activity an enzyme 5`-nucleotidase in patients with chronic hepatitis C
Galeeva N., Valeeva I.
Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
Kostyushev D., Zueva A., Brezgin S., Lipatnikov A., Simirskii V., Glebe D., Volchkova E., Shipulin G., Chulanov V.
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
Znoyko O., Klimova E., Maevskaya M., Shuldyakov А., Linkova Y., Morozova M.
Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C
Taratina O., Krasnova T., Samokhodskaia L., Lopatkina T., Tkachuk V., Mukhin N.
Metabolic correctors based on siccine acid as pathogenic therapy in chronic virus hepatitis
Stel'makh V., Radchenko V., Kozlov V., Stelmakh V., Radchenko V., Kozlov V.
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C
Bayzhanova Z., Ignatova T., Nekrasova T., Baizhanova Z., Ignatova T., Nekrasova T.
HBeAg-negative chronic hepatitis
Ibragimova M., Krel P., Abdurakhmanov D.
51 - 67 的 67 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语